mDETECT Inc.
2 known investors
mDETECT develops a circulating tumor DNA detection test capable of identifying cancer markers at ultra-sensitive levels across multiple cancer types including breast, ovarian, lung, and prostate. The test integrates with existing sequencing platforms and is designed for automated workflows in diagnostic and clinical settings.
AI & Machine LearningDeep TechMedical Devices